Zuanic & Associates

The Florida cannabis market is experiencing impressive growth, setting the stage for the potential legalization of recreational use. As it stands, Florida's medical marijuana market already boasts an impressive valuation of over $1.4 billion with a remarkable volume growth rate...

Maryland stands as a shining example of a medical cannabis state transitioning smoothly into the recreational market. According to a financial report by Zuanic & Associates, (Z&A), this transition has been particularly beneficial for incumbent medical cannabis players, who have witnessed a...

Canada’s medical cannabis landscape is facing a profound transformation. Since the legalization of recreational marijuana in 2018, there has been a steep decline in both patient registrations and spending. The challenge now lies in deciphering the reasons and navigating future implications....

US legal cannabis sales are predicted to exceed $28 billion in 2023, with promising regulatory developments such as the recommendation to "reschedule" cannabis by the HHS. Canada's cannabis exports have surged to C$160 million, a 50% increase year-on-year, and with new international...

As the cannabis industry continues to evolve, revealing data analysis by Zuanic & Associates sheds light on a captivating paradox: while flower sales have shown signs of growth, their dominance has waned, unveiling a changing landscape. Over nearly three years, flower sales have bloomed by 62...

The Department of Health and Human Services (HHS) suggested the DEA reclassify cannabis as a Schedule III controlled substance under federal law. Assistant Secretary for Health Rachel Levine's letter triggered a much-needed rally in cannabis stocks. In a recent analyst note, a...

The Department of Health and Human Services' recommendation to reclassify marijuana as a Schedule III drug under the Controlled Substances Act set off ripples across the cannabis market. One day following Wednesday's news, MSOS ETF (ARCA: MSOS) surged by 21%. Notable companies also...

Recent news that the Department of Health and Human Services (HHS) is recommending the reclassification of marijuana as a Schedule III drug under the Controlled Substances Act has ignited significant market reactions. On the day following the report, MSOS ETF (ARCA: MSOS) surged...

Zuanic & Associates' recent report unveils the movers and shakers in the flower segment, shedding light on their market shares, pricing strategies and fortunes. The second quarter of 2023 saw some intriguing shifts in the sector. When it comes to market leaders in the flower segment,...

In a recent report by Zuanic & Associates, a comprehensive analysis of Canada's cannabis industry highlights both promising growth trends and concerning gaps in comparison to the United States. The data reveals that while Canada's cannabis market is experiencing decent growth, it falls...

The introduction of recreational cannabis sales has brought about significant shifts in the medical marijuana (MMJ) landscape across several states, impacting sales and patient counts. In many states, MMJ sales have experienced double-digit declines following the onset of recreational sales....

Maryland's recreational cannabis sales, which began in July 2023, surged impressively in just the first month, reaching $87.3 million. According to analysis firm, Zuanic & Associates, this significant growth, although promising, falls slightly short of expectations given the state's...

The Canadian cannabis market is abuzz with competition. The latest data from Hifyre, as analyzed by Zuanic & Associates, highlights a heated race in the pre-roll segment. In the second quarter of 2023, a staggering 1,475 pre-roll SKUs were registered, originating from a diverse pool of 148...

Cannabis pre-rolls are emerging as a key driver of the growth of Canada’s recreational cannabis market. Which other cannabis products have seen significant growth in the second quarter of 2023? And, how do these trends provide valuable insights for industry players in Canada's...

The potential of rescheduling and removing Tax Rule 280E could boost profits for U.S. businesses. However, Zuanic and Associates' latest report reveals complexities and overlooked consequences. What is the best option for unlocking the cannabis industry's potential: exploring...